MYO Logo

Myomo, Inc. (MYO) 

AMEX
Market Cap
$86.44M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
151 of 809
Rank in Industry
16 of 107

Largest Insider Buys in Sector

MYO Stock Price History Chart

MYO Stock Performance

About Myomo, Inc.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Insider Activity of Myomo, Inc.

Over the last 12 months, insiders at Myomo, Inc. have bought $647,496 and sold $267,082 worth of Myomo, Inc. stock.

On average, over the past 5 years, insiders at Myomo, Inc. have bought $258,442 and sold $123,518 worth of stock each year.

Highest buying activity among insiders over the last 12 months: KIRK THOMAS F (director) — $505,000. GUDONIS PAUL R (Chief Executive Officer) — $96,630. HENRY DAVID A (Chief Financial Officer) — $49,999.

The last purchase of 50,000 shares for transaction amount of $175,000 was made by KIRK THOMAS F (director) on 2024‑05‑29.

List of Insider Buy and Sell Transactions, Myomo, Inc.

2024-05-29PurchaseKIRK THOMAS Fdirector
50,000
0.174%
$3.50$175,000-1.87%
2024-05-15SaleKovelman HarryChief Medical Officer
35,426
0.1201%
$3.69$130,839-8.20%
2024-03-14PurchaseKIRK THOMAS Fdirector
50,000
0.1683%
$3.50$175,0000.00%
2023-12-08SaleCrowley Thomas Aloysius Jr.director
14,997
0.0571%
$4.08$61,188-11.63%
2023-12-01SaleKovelman HarryChief Medical Officer
8,333
0.0296%
$3.12$26,016+7.51%
2023-11-28SaleCrowley Thomas Aloysius Jr.director
14,997
0.0574%
$3.27$49,040+11.21%
2023-11-20PurchaseKIRK THOMAS Fdirector
50,000
0.1929%
$3.10$155,000+16.97%
2023-09-08PurchaseMorris Milton Mayodirector
15,000
0.0565%
$1.06$15,867+216.98%
2023-08-30PurchaseGUDONIS PAUL RChief Executive Officer
48,400
0.2365%
$0.74$36,039+350.32%
2023-08-29PurchaseGUDONIS PAUL RChief Executive Officer
37,000
0.1804%
$0.78$28,797+322.74%
2023-08-29PurchaseHENRY DAVID AChief Financial Officer
41,666
0.1566%
$0.60$25,000+322.74%
2023-08-29PurchaseKovelman HarryChief Medical Officer
8,333
0.0313%
$0.60$5,000+322.74%
2023-08-28PurchaseGUDONIS PAUL RChief Executive Officer
42,500
0.1883%
$0.75$31,794+316.25%
2023-01-17PurchaseGUDONIS PAUL RChief Executive Officer
307,692
0.9391%
$0.33$100,000+66.02%
2023-01-17PurchaseHENRY DAVID AChief Financial Officer
76,923
0.2348%
$0.33$25,000+66.02%
2023-01-17PurchaseMitchell MicahChief Commerical Officer
15,384
0.047%
$0.33$5,000+66.02%
2022-11-22PurchaseHENRY DAVID AChief Financial Officer
9,000
0.1177%
$0.55$4,960+12.54%
2022-08-05SaleCrowley Thomas Aloysius Jr.
7,141
0.1017%
$1.71$12,218-60.94%
2022-06-14SaleCrowley Thomas Aloysius Jr.director
291
0.0041%
$1.67$485-58.19%
2022-06-10SaleCrowley Thomas Aloysius Jr.director
6,000
0.0849%
$1.97$11,790-63.99%

Insider Historical Profitability

<0.0001%
GUDONIS PAUL RChief Executive Officer
878245
3.3121%
$3.0090<0.0001%
HENRY DAVID AChief Financial Officer
352193
1.3282%
$3.0050<0.0001%
Kovelman HarryChief Medical Officer
98009
0.5312%
$3.0012
KIRK THOMAS Fdirector
236499
0.5148%
$3.0050<0.0001%
Morris Milton Mayodirector
77933
0.2939%
$3.0010
Crowley Thomas Aloysius Jr.director
29994
0.1131%
$3.0008
SANGHI STEVEdirector
298513
1.1258%
$3.0010
Naft JonathanVP, GENERAL MANAGER
74114
0.2795%
$3.0010
Mitchell MicahChief Commerical Officer
64815
0.2444%
$3.0012+66.02%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Aigh Capital Management Llc$9.16M9.732.8M+5.03%+$439,167.555.44
Herr Investment Group Llc$5.38M5.711.65M+67.86%+$2.18M1.74
The Vanguard Group$3.81M4.051.17M-4.22%-$168,198.98<0.0001
ESSEX INVESTMENT MANAGEMENT CO LLC$1.97M2.09602,744+537.86%+$1.66M0.39
Renaissance Technologies$921,000.000.98281,700+45.51%+$288,037.27<0.01
Geode Capital Management$724,865.000.77221,621+15.91%+$99,473.06<0.0001
Legato Capital Management Llc$711,307.000.76217,525New+$711,307.000.09
Bridgeway Capital Management$297,570.000.3291,000+121.95%+$163,500.000.01
State Street$267,731.000.2881,875+29.39%+$60,821.94<0.0001
Marshall Wace$204,898.000.2262,660-36.04%-$115,447.24<0.0001
Stratos Wealth Partners$163,500.000.1750,000+100%+$81,750.00<0.01
Pfg Advisors$152,905.000.1646,760+74.84%+$65,452.230.01
Northern Trust$138,030.000.1542,211-19.22%-$32,843.89<0.0001
Accel Wealth Management$135,319.000.1441,382New+$135,319.000.06
BlackRock$112,269.000.1234,333+1.42%+$1,569.60<0.0001
Accurate Wealth Management Llc$68,791.000.0821,5650%+$00.02
Charles Schwab$70,289.000.0821,495New+$70,289.00<0.0001
Clearstead Advisors Llc$47,066.000.0512,9300%+$0<0.01
Morgan Stanley$36,045.000.0411,023-13.29%-$5,526.27<0.0001
Summit Financial Strategies, Inc.$32,700.000.0410,0000%+$00.01
UBS$26,124.000.037,989New+$26,124.00<0.0001
Advisor Group Holdings Inc$16,350.000.025,000-32.89%-$8,011.50<0.0001
Tower Research Capital$15,464.000.024,729-48.91%-$14,806.72<0.0001
The Bollard Group$5,000.000.011,5700%+$0<0.0001
Simplex Trading Llc$5,000.000.011,536New+$5,000.00<0.0001
LAZARD ASSET MANAGEMENT LLC$2,000.00<0.01704-1.54%-$31.25<0.0001
Bank of America$2,093.00<0.01640+2,185.71%+$2,001.43<0.0001
Newedge Advisors Llc$1,789.00<0.01547New+$1,789.00<0.0001
Wells Fargo$693.00<0.01212+6%+$39.23<0.0001
Northwestern Mutual Wealth Management Co$98.00<0.0130New+$98.00<0.0001